跳至主要内容
临床试验/NL-OMON46342
NL-OMON46342招募中不适用

Blood- and urinary levels of different carnitine-esters during administration of oxaliplatin based chemotherapy - Carnitine levels during oxaliplatin infusion

Maxima Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Written informed consent
  • 2. Age >18 years
  • 3. Start treatment with oxaliplatin-based chemotherapy
  • 4. Understanding the Dutch language

排除标准

  • 1. Patients with known primary carnitine deficiency (congenital)
  • 2. Patients on haemodialysis or peritoneal dialysis
  • 3. Patients with epilepsy
  • 4. Current treatment with valproic acid or zidovudine
  • 5. Current use of carnitine supplements or use of carnitine supplements in the past 3 months
  • 6. Pre-existent neuropathy or comorbid disorder causing neuropathy
  • 7. Previous treatment with neurotoxic chemotherapy
  • 8. Participation in an intervention study on CIPN (e.g. Frozen Gloves)

研究者

发起方
Maxima Medisch Centrum

相似试验